FDA's Woodcock on New Unit to Boost Drug Oversight

Feb. 14 (Bloomberg) -- Janet Woodcock, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, speaks about the agency's decision to form a new unit to improve the FDA's scrutiny of brand-name, generic and over-the-counter drugs. Woodcock speaks at the Bloomberg 2014 State of Health Care summit in New York. (Source: Bloomberg)

Google Search: Crystal Ball for Election Results?
20:23 - Khosla Ventures partner Keith Rabois, Braintree head of commerce Harper Reed and Bloomberg’s Tim Higgins discuss how campaigns can use Google search data with Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Apple Said to Produce New Show Starring Dr. Dre
  • Can PayPal Commerce Stand Up to Competition?
  • How Medium Recruits High Profile Writers